Stryker, Inari Medical

Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical
Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.
Stryker agrees to acquire Inari Medical for $4.9bn
Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly $4.9bn. Inari is poised to enhance Stryker's footprint in the peripheral vascular sector, particularly in the venous thromboembolism (VTE) market.
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Medical device maker Stryker announces $4.9 billion deal for Inari Medical
Stryker said on Monday that the medical-device maker will buy Inari Medical, which makes devices that treat patients with venous diseases, in a $4.9 billion deal. The deal for Inari, which has a market value of nearly $3 billion,
BofA goes to No Rating on Inari Medical after takeover deal
BofA is moving to No Rating on Inari Medical (NARI) after Stryker agreed to acquire Inari for $4.9B, or $80 in cash per share. Given the deal
Stryker to Buy Inari Medical in $4.9 Billion Deal
Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal worth roughly $4.9 billion as the company looks to boost its neurovascular and endovascular segments.
Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired ...
WATCH: Ukraine's AFV Stryker With No Ammo Left Chases Down Russian Troops
Russia has been battling Ukraine in Kursk since August 2024, when Kyiv launched a surprise cross-border incursion into ...
Stryker price target raised to $425 from $410 at Bernstein
Bernstein raised the firm’s price target on Stryker (SYK) to $425 from $410 and keeps an Outperform rating on the shares as part of a broader ...
Peoria Fire Department to roll out new cardiac monitor technology
The Peoria Fire Department is embracing new technology that could help save lives out in the field. The Peoria Fire ...
Stryker Corp. stock outperforms competitors despite losses on the day
Stryker Corp. closed $36.84 short of its 52-week high ($398.20), which the company achieved on November 18th.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...